New Antibiotics Might Speed Thru FDA

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Addressing rising concerns of “superbugs,” plans have been proposed to push new antibiotics through the FDA process on a fast track. These new drugs would be designed specifically to fight infections resistant to exiting antibiotics — skipping tests usually required until after the drugs are already being used.

The New York Times reports that Dr. John H. Powers, a former F.D.A. antibiotics reviewer, worries that drug companies might have little incentive to broadly test such an antibiotic once it’s been approved for use on a small group. Unless safeguards are put in place, it might eventually be used in millions of people without full knowledge of side effects and long-term effects.

–MedShadow Staff

Did you find this article helpful?

Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement